130 related articles for article (PubMed ID: 36635327)
21. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response.
Arora R; Cao C; Kumar M; Sinha S; Chanda A; McNeil R; Samuel D; Arora RK; Matthews TW; Chandarana S; Hart R; Dort JC; Biernaskie J; Neri P; Hyrcza MD; Bose P
Nat Commun; 2023 Aug; 14(1):5029. PubMed ID: 37596273
[TBL] [Abstract][Full Text] [Related]
22. Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma.
Thomas P; Preethi KA; Selvakumar SC; Ramani P; Sekar D
J Oral Maxillofac Pathol; 2023; 27(2):364-373. PubMed ID: 37854932
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic implications of genetic alterations in oral cancers.
Pathare SM; Gerstung M; Beerenwinkel N; Schäffer AA; Kannan S; Pai P; Pathak KA; Borges AM; Mahimkar MB
Oncol Lett; 2011 May; 2(3):445-451. PubMed ID: 21546976
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial DNA content as a biomarker for oral carcinogenesis: correlation with clinicopathologic parameters.
Raina R; Shetty DC; Nasreen N; DAS S; Sethi A; Chikara A; Rai G; Kumar A; Tulsyan S; Sisodiya S; Hussain S
Minerva Dent Oral Sci; 2023 Oct; 72(5):211-220. PubMed ID: 37066891
[TBL] [Abstract][Full Text] [Related]
25. Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).
Jiao F; Jin Z; Wang L; Wang L
Biomed Rep; 2013 Nov; 1(6):819-827. PubMed ID: 24649035
[TBL] [Abstract][Full Text] [Related]
26. IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism.
Liu TY; Hu CC; Han CY; Mao SY; Zhang WX; Xu YM; Sun YJ; Jiang DB; Zhang XY; Zhang JX; Wang J; Qiao XP; Pan JY; Yang SY; Yang K
Biol Direct; 2023 Apr; 18(1):19. PubMed ID: 37088822
[TBL] [Abstract][Full Text] [Related]
27. Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier.
Wu X; Jiao Z; Zhang J; Li F; Li Y
J Nanobiotechnology; 2023 Apr; 21(1):126. PubMed ID: 37041636
[TBL] [Abstract][Full Text] [Related]
28. The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy.
Moran B; Davern M; Reynolds JV; Donlon NE; Lysaght J
Cancer Lett; 2023 Apr; 559():216121. PubMed ID: 36893893
[TBL] [Abstract][Full Text] [Related]
29. Response to 'Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC' by Yang
Li K; Qin Y; Ye L
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36882227
[No Abstract] [Full Text] [Related]
30. Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.
Akce M; El-Rayes BF; Wajapeyee N
Oncogene; 2023 Mar; 42(14):1051-1057. PubMed ID: 36854723
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition.
Tao S; Liang S; Zeng T; Yin D
Front Immunol; 2022; 13():1043667. PubMed ID: 36685594
[TBL] [Abstract][Full Text] [Related]
32. The m
Xie J; Mo T; Li R; Zhang H; Liang G; Ma T; Chen J; Xie H; Wen X; Hu T; Xian Z; Pan W
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001714
[TBL] [Abstract][Full Text] [Related]
33. Anatomical landscape of oral squamous cell carcinoma: A single cancer center study in UAE.
Al-Rawi NH; Hachim IY; Hachim MY; Salmeh A; Uthman AT; Marei H
Heliyon; 2023 May; 9(5):e15884. PubMed ID: 37206025
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
35. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
36. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
37. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
Christianto S; Li KY; Huang TH; Su YX
Laryngoscope; 2022 Sep; 132(9):1760-1770. PubMed ID: 34953144
[TBL] [Abstract][Full Text] [Related]
39. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
